These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26340409)

  • 1. Single point mutations in the helicase domain of the NS3 protein enhance dengue virus replicative capacity in human monocyte-derived dendritic cells and circumvent the type I interferon response.
    Silveira GF; Strottmann DM; de Borba L; Mansur DS; Zanchin NI; Bordignon J; dos Santos CN
    Clin Exp Immunol; 2016 Jan; 183(1):114-28. PubMed ID: 26340409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules.
    Costa VV; Ye W; Chen Q; Teixeira MM; Preiser P; Ooi EE; Chen J
    mBio; 2017 Aug; 8(4):. PubMed ID: 28765218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue virus NS1 enhances viral replication and pro-inflammatory cytokine production in human dendritic cells.
    Alayli F; Scholle F
    Virology; 2016 Sep; 496():227-236. PubMed ID: 27348054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue-2 and yellow fever 17DD viruses infect human dendritic cells, resulting in an induction of activation markers, cytokines and chemokines and secretion of different TNF-α and IFN-α profiles.
    Gandini M; Reis SR; Torrentes-Carvalho A; Azeredo EL; Freire Mda S; Galler R; Kubelka CF
    Mem Inst Oswaldo Cruz; 2011 Aug; 106(5):594-605. PubMed ID: 21894381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
    Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K
    J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex.
    Rodriguez-Madoz JR; Belicha-Villanueva A; Bernal-Rubio D; Ashour J; Ayllon J; Fernandez-Sesma A
    J Virol; 2010 Oct; 84(19):9760-74. PubMed ID: 20660196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis.
    Libraty DH; Pichyangkul S; Ajariyakhajorn C; Endy TP; Ennis FA
    J Virol; 2001 Apr; 75(8):3501-8. PubMed ID: 11264339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral Source-Independent High Susceptibility of Dendritic Cells to Human T-Cell Leukemia Virus Type 1 Infection Compared to That of T Lymphocytes.
    Alais S; Mahieux R; Dutartre H
    J Virol; 2015 Oct; 89(20):10580-90. PubMed ID: 26269171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of high doses of vitamin D supplementation on dengue virus replication, Toll-like receptor expression, and cytokine profiles on dendritic cells.
    Martínez-Moreno J; Hernandez JC; Urcuqui-Inchima S
    Mol Cell Biochem; 2020 Jan; 464(1-2):169-180. PubMed ID: 31758375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different innate signatures induced in human monocyte-derived dendritic cells by wild-type dengue 3 virus, attenuated but reactogenic dengue 3 vaccine virus, or attenuated nonreactogenic dengue 1-4 vaccine virus strains.
    Balas C; Kennel A; Deauvieau F; Sodoyer R; Arnaud-Barbe N; Lang J; Guy B
    J Infect Dis; 2011 Jan; 203(1):103-8. PubMed ID: 21148502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of dengue virus replication in monocyte-derived dendritic cells by vivo-morpholino oligomers.
    Phumesin P; Junking M; Panya A; Yongpitakwattana P; Noisakran S; Limjindaporn T; Yenchitsomanus PT
    Virus Res; 2019 Jan; 260():123-128. PubMed ID: 30503719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus.
    Tsai CY; Liong KH; Gunalan MG; Li N; Lim DS; Fisher DA; MacAry PA; Leo YS; Wong SC; Puan KJ; Wong SB
    J Immunol; 2015 Apr; 194(8):3890-900. PubMed ID: 25732728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication.
    Chatel-Chaix L; Fischl W; Scaturro P; Cortese M; Kallis S; Bartenschlager M; Fischer B; Bartenschlager R
    J Virol; 2015 Jul; 89(14):7170-86. PubMed ID: 25926641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of interferon alpha by dengue virus-infected human monocytes.
    Kurane I; Ennis FA
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():445-9. PubMed ID: 3339332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the domain interactions between the protease and helicase of NS3 in dengue and hepatitis C virus.
    Rosales-León L; Ortega-Lule G; Ruiz-Ordaz B
    J Mol Graph Model; 2007 Jan; 25(5):585-94. PubMed ID: 16762573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse models for dengue vaccines and antivirals.
    Plummer EM; Shresta S
    J Immunol Methods; 2014 Aug; 410():34-8. PubMed ID: 24440090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DENV inhibits type I IFN production in infected cells by cleaving human STING.
    Aguirre S; Maestre AM; Pagni S; Patel JR; Savage T; Gutman D; Maringer K; Bernal-Rubio D; Shabman RS; Simon V; Rodriguez-Madoz JR; Mulder LC; Barber GN; Fernandez-Sesma A
    PLoS Pathog; 2012; 8(10):e1002934. PubMed ID: 23055924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus.
    Lim DS; Yawata N; Selva KJ; Li N; Tsai CY; Yeong LH; Liong KH; Ooi EE; Chong MK; Ng ML; Leo YS; Yawata M; Wong SB
    J Immunol; 2014 Nov; 193(10):5065-75. PubMed ID: 25320280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhodiola inhibits dengue virus multiplication by inducing innate immune response genes RIG-I, MDA5 and ISG in human monocytes.
    Diwaker D; Mishra KP; Ganju L; Singh SB
    Arch Virol; 2014 Aug; 159(8):1975-86. PubMed ID: 24590566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication.
    Matusan AE; Pryor MJ; Davidson AD; Wright PJ
    J Virol; 2001 Oct; 75(20):9633-43. PubMed ID: 11559795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.